Validation and next-generation update of a DNA methylation-based recurrence predictor for meningioma: a multicenter prospective study.
Landry AP, Wang JZ, Patil V, Gui C, Yasin M, Patel Z, Yakubov R, Kaloti R, Habibi P, Wilson M, Ajisebutu A, Ellenbogen Y, Wei Q, Singh O, Sosa J, Mansouri S, Wilson C, Cohen-Gadol AA, Virtanen P, Burket N, Blackwell M, Koenig J, Alfonso A, Davis J, Zaazoue MA, Tabatabai G, Tatagiba M, Behling F, Barnholtz-Sloan JS, Sloan AE, Chotai S, Chambless LB, Mansouri A, Ehret F, Capper D, Tsang DS, Aldape K, Gao A; International Consortium on Meningiomas (ICOM); Nassiri F, Zadeh G.
Landry AP, et al. Among authors: sloan ae.
Neuro Oncol. 2024 Nov 6:noae236. doi: 10.1093/neuonc/noae236. Online ahead of print.
Neuro Oncol. 2024.
PMID: 39503370